Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Altered Gut Microbiota and Its Metabolites in Cystic Fibrosis
Aravind Thavamani, Iman Salem, Thomas J. Sferra, et al.
Metabolites (2021) Vol. 11, Iss. 2, pp. 123-123
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Respiratory dysfunction three months after severe COVID‐19 is associated with gut microbiota alterations
Beate Vestad, Thor Ueland, Tøri Vigeland Lerum, et al.
Journal of Internal Medicine (2022) Vol. 291, Iss. 6, pp. 801-812
Open Access | Times Cited: 59
Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders
Senthilkumar Sankararaman, Kimberly Janelle Noriega, Sujithra Velayuthan, et al.
Current Gastroenterology Reports (2022) Vol. 25, Iss. 2, pp. 31-44
Closed Access | Times Cited: 50
What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?
Josie van Dorst, Rachel Y. Tam, Chee Y. Ooi
Nutrients (2022) Vol. 14, Iss. 3, pp. 480-480
Open Access | Times Cited: 43
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Piero Portincasa, Mohamad Khalil, Annarita Graziani, et al.
European Journal of Internal Medicine (2023) Vol. 119, pp. 13-30
Closed Access | Times Cited: 28
ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis
Michael Wilschanski, À. Munck, Estefania Carrion, et al.
Clinical Nutrition (2023) Vol. 43, Iss. 2, pp. 413-445
Closed Access | Times Cited: 26
Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions
Rachel Y. Tam, Josie van Dorst, Isabelle McKay, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 649-649
Open Access | Times Cited: 31
Diagnosis, management, and outcomes of pediatric tracheostomy‐associated infections: A scoping review
John M. Morrison, Amir Hassan, Lynn Kysh, et al.
Pediatric Pulmonology (2022) Vol. 57, Iss. 5, pp. 1145-1156
Open Access | Times Cited: 26
Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome
Ryan Marsh, Claudio Dos Santos, Liam Hanson, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 15
Venous Thromboembolism Occurrence and Association with Gastrointestinal Disorders in Children with Cystic Fibrosis: An Analysis from the TriNetX Research Network Global Multicenter Real-World Dataset
Carolena Trocchia, Dina Ashour, Maua Mosha, et al.
Seminars in Thrombosis and Hemostasis (2025)
Closed Access
Critical analysis of updated international recommendations on nutrition of patients with cystic fibrosis
N. Kashirskaya, О. И. Симонова, Ina Sokolov, et al.
Experimental and Clinical Gastroenterology (2025), Iss. 8, pp. 163-180
Closed Access
Effectiveness of Probiotics, Prebiotics, and Symbiotic Supplementation in Cystic Fibrosis Patients: A Systematic Review and Meta-Analysis of Clinical Trials
Freiser Eceomo Cruz Mosquera, Claudia Lorena Perlaza, Anisbed Naranjo Rojas, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 489-489
Open Access
CFTR and Gastrointestinal Cancers: An Update
Rahul Bhattacharya, Zachary Blankenheim, Patricia M. Scott, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 868-868
Open Access | Times Cited: 19
Resolution of inflammation in chronic disease via restoration of the heat shock response (HSR)
Helena Trevisan Schroeder, Carlos Henrique de Lemos Muller, Thiago Gomes Heck, et al.
Cell Stress and Chaperones (2024) Vol. 29, Iss. 1, pp. 66-87
Open Access | Times Cited: 4
Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review
Aref Yarahmadi, Hamed Afkhami, Ali Javadi, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
The Gut–Liver Axis in Pediatric Liver Health and Disease
Stephanie L. Rager, Melody Y. Zeng
Microorganisms (2023) Vol. 11, Iss. 3, pp. 597-597
Open Access | Times Cited: 9
Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons
Mohammed Al‐Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, et al.
World Journal of Clinical Pediatrics (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 3
Probiotics Administration in Cystic Fibrosis: What Is the Evidence?
Susanna Esposito, Ilaria Testa, Elena Mariotti Zani, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3160-3160
Open Access | Times Cited: 13
Regulation effect of the intestinal flora and intervention strategies targeting the intestinal flora in alleviation of pulmonary fibrosis development
Jianquan GUO, Liyang YANG
Bioscience of Microbiota Food and Health (2024) Vol. 43, Iss. 4, pp. 293-299
Open Access | Times Cited: 2
Impacts of PFOS, PFOA and their alternatives on the gut, intestinal barriers and gut-organ axis
Boxiang Zhang, Yunhui Yang, Qing X. Li, et al.
Chemosphere (2024) Vol. 361, pp. 142461-142461
Closed Access | Times Cited: 2
In vitro screening of the impact of dietary prebiotic components, probiotic strains, and their symbiotic combinations on colonic microbiota in children with cystic fibrosis
Jazmín Viteri-Echeverría, Ana Andrés, Joaquim Calvo‐Lerma, et al.
Food & Function (2024) Vol. 15, Iss. 12, pp. 6512-6522
Open Access | Times Cited: 2
Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?
Giovanna Batoni, Giuseppantonio Maisetta, Esingül Kaya, et al.
Antibiotics (2022) Vol. 11, Iss. 3, pp. 326-326
Open Access | Times Cited: 12
Can Bioactive Food Substances Contribute to Cystic Fibrosis-Related Cardiovascular Disease Prevention?
Laura Mihaela Trandafir, Otilia Elena Frăsinariu, Elena Ţarcă, et al.
Nutrients (2023) Vol. 15, Iss. 2, pp. 314-314
Open Access | Times Cited: 6
Gut Dysbiosis in Children with Cystic Fibrosis: Development, Features and the Role of Gut–Lung Axis on Disease Progression
Ilaria Testa, Oliviero Crescenzi, Susanna Esposito
Microorganisms (2022) Vol. 11, Iss. 1, pp. 9-9
Open Access | Times Cited: 9
Resilience and stability of the CF- intestinal and respiratory microbiome during nutritional and exercise intervention
Rebecca L. Knoll, Víctor Hugo Jarquín‐Díaz, Jonas Klopp, et al.
BMC Microbiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Gut microbial dysbiosis occurring during pulmonary fungal infection in rats is linked to inflammation and depends on healthy microbiota composition
Dušanka Popović, Jelena Kulaš, Dina Tucović, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top